Skip to main content
Discover what's not being covered
Get Started
SubscribeLogin
Published • loading... • Updated

Biogenera Revives Euronext Plans with €5M Crowdfunding

Summary by Born2Invest
Biogenera is nearing the October 26 deadline for its CrowdFundMe equity crowdfunding campaign, targeting approximately €5 million. The Italian biotech aims to list on Euronext within two years. Its lead candidate, BGA002, targets aggressive pediatric tumors but remains preclinical. Phase I trials are planned for 2027, requiring additional funding to proceed.

2 Articles

Born2InvestBorn2Invest
Center

Biogenera Revives Euronext Plans with €5M Crowdfunding

Biogenera is nearing the October 26 deadline for its CrowdFundMe equity crowdfunding campaign, targeting approximately €5 million. The Italian biotech aims to list on Euronext within two years. Its lead candidate, BGA002, targets aggressive pediatric tumors but remains preclinical. Phase I trials are planned for 2027, requiring additional funding to proceed.

Read Full Article
teleborsa.itteleborsa.it

Biogenera Returns to Crowdfunding and Points Back to the Stock Exchange: the Campaign Closes on October 26

(Teleborsa) - Biogenerate, a biotech company in Ozzano dell'Emilia (Bologna) that develops anti-gene drugs based on PNA, is in the last week of a new equity crowdfunding campaign on CrowdFundMe...

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

teleborsa.it broke the news on Wednesday, October 21, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Technology icon

Technology

Italy icon

Italy

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal